Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Approves New Wrinkle Relaxer - Happi
Company News

FDA Approves New Wrinkle Relaxer

Dysport said to rival Botox in category

The U.S. Food and Drug Administration (FDA) has approved Dysport, a “next generation” acetylcholine release inhibitor and neuromuscular blocking agent indicated for the temporary improvement of the appearance of moderate to severe glabellar or frown lines between the brows. Dysport, marketed by Medicis Aesthetics, the distributers of Restylane and Perlane, has been used in over two million treatments worldwide in 27 countries.

Studies and patient reports have shown that Dysport may last up to eight months compared to the four to six months that Botox is effective, according to the company.It has been evaluated for safety and efficacy in clinical studies which included approximately 3,000 patients and 10,000 injections at more than 80 study sites in the U.S.

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters